Effects of Telbivudine Treatment on the Circulating CD4+ T-Cell Subpopulations in Chronic Hepatitis B Patients
Figure 3
Correlation between the signature transcription factors of CD4+ T-cell subtypes and HBV DNA level. Expressions of the signature transcription factors for each of the CD4+ T-cell subtypes and HBV DNA level at various time points of treatment (baseline and weeks 12, 24, 36, and 52) are indicated on the plots by diamonds. Error bars indicate SEM.
